Extraarticular Manifestations and Comorbidities in Patients With Rheumatoid Arthritis

References

1. 1.↵
   1. Gunderson TM,
   2. Myasoedova E,
   3. Davis JM 3rd,
   4. Crowson CS

   . Multimorbidity burden in rheumatoid arthritis: a population-based cohort study. J Rheumatol 2021;48:1648-54.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Sayah A,
   2. English JC 3rd

   . Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol 2005;53:191-209.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Dequeker J,
   2. Geusens P

   . Osteoporosis and arthritis. Ann Rheum Dis 1990;49:276-80.

   OpenUrlFREE Full Text
4. 4.↵
   1. Hanly JG,
   2. Lethbridge L

   . Use of disease-modifying antirheumatic drugs, biologics, and corticosteroids in older patients with rheumatoid arthritis over 20 years. J Rheumatol 2021;48:977-84.

   OpenUrlAbstract/FREE Full Text
5. 5.↵
   1. Jin Z,
   2. Xiang C,
   3. Cai Q,
   4. Wei X,
   5. He J

   . Alcohol consumption as a preventive factor for developing rheumatoid arthritis: a dose-response meta-analysis of prospective studies. Ann Rheum Dis 2014;73:1962-7.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Humphreys JH,
   2. Warner A,
   3. Costello R,
   4. Lunt M,
   5. Verstappen SMM,
   6. Dixon WG

   . Quantifying the hepatotoxic risk of alcohol consumption in patients with rheumatoid arthritis taking methotrexate. Ann Rheum Dis 2017;76:1509-14.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Meer E,
   2. Thrastardottir T,
   3. Wang X, et al

   . Risk factors for diagnosis of psoriatic arthritis, psoriasis, rheumatoid arthritis, and ankylosing spondylitis: a set of parallel case-control studies. J Rheumatol 2022;49:53-9.

   OpenUrlAbstract/FREE Full Text